Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Curcumin, Resveratrol, and Stinging Nettle as Treatments for Gulf War Illness

NCT05377242 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT05377242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05377242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Curcumin, Resveratrol, and Stinging Nettle as Treatments for Gulf War Illness
Lead sponsor
University of Alabama at Birmingham
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2023
Completion date
June 22, 2026
Enrollment
390 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gulf war illness